Titleist Asset Management LLC Sells 281 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Titleist Asset Management LLC decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,349 shares of the exchange traded fund’s stock after selling 281 shares during the period. Titleist Asset Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,202,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of XBI. FMR LLC lifted its position in SPDR S&P Biotech ETF by 13.6% during the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock valued at $686,000 after acquiring an additional 830 shares during the last quarter. Ameritas Advisory Services LLC increased its position in shares of SPDR S&P Biotech ETF by 11.9% during the fourth quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock worth $962,000 after purchasing an additional 1,137 shares in the last quarter. Van ECK Associates Corp purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $1,497,000. Parallel Advisors LLC boosted its position in shares of SPDR S&P Biotech ETF by 3.8% in the 4th quarter. Parallel Advisors LLC now owns 42,574 shares of the exchange traded fund’s stock worth $3,834,000 after purchasing an additional 1,568 shares in the last quarter. Finally, Runnymede Capital Advisors Inc. purchased a new position in SPDR S&P Biotech ETF during the 4th quarter worth $160,000.

SPDR S&P Biotech ETF Trading Down 5.7 %

NYSEARCA XBI opened at $73.66 on Friday. The stock has a market cap of $4.65 billion, a P/E ratio of 11.47 and a beta of 1.00. SPDR S&P Biotech ETF has a 12-month low of $73.25 and a 12-month high of $105.47. The company has a fifty day simple moving average of $88.13 and a two-hundred day simple moving average of $93.17.

SPDR S&P Biotech ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Wednesday, March 26th. Investors of record on Monday, March 24th were paid a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.